Human iPSC–Derived Endothelial Cells Exhibit Reduced Immunogenicity in Comparison With Human Primary Endothelial Cells
Human induced pluripotent stem cell (iPSC)–derived endothelial cells (ECs) have emerged as a promising source of autologous cells with great potential to produce novel cell therapy for ischemic vascular diseases. However, their clinical application still faces numerous challenges including safety co...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/sci/6153235 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|